We @conviction are excited to announce our investment in Xlue!
Models today are excellent academics; they’ve read every scientific paper ever published, but still can’t tell when you’ll fall sick or what treatment will work when you do. To get models to be MDs instead of PhDs, we need to treat the problem differently. Your health isn’t a next token prediction problem! We should deeply understand your current state and use the many trajectories our model has observed to predict what will happen next.
Xlue’s early work here is already state of the art — in a double blind disease prediction study by a third party, the Xlue Health World Model substantially outperforms frontier models (Astra, Opus, etc.) and traditional machine learning models on a tiny fraction of the compute. Already, providers are using their models to improve preventative care, pharmaceutical companies to find expanded uses for existing drugs.
Chenyan and team are obviously brilliant. They’ve led pretraining at trillion parameter scale, moved research into production systems that touched billions of people, and shipped products that improved the lives of millions of patients. Beyond their technical brilliance, I was struck most by how determined and truth-seeking the team is. When we first met Chenyan, I remarked that they had earned the trust of their early partners by underpromising and overdelivering. Chenyan corrected me — the team had correctly promised, and correctly delivered.
So I take Xlue’s promise to save millions of lives pretty seriously.
Models today are excellent academics; they’ve read every scientific paper ever published, but still can’t tell when you’ll fall sick or what treatment will work when you do. To get models to be MDs instead of PhDs, we need to treat the problem differently. Your health isn’t a next token prediction problem! We should deeply understand your current state and use the many trajectories our model has observed to predict what will happen next.
Xlue’s early work here is already state of the art — in a double blind disease prediction study by a third party, the Xlue Health World Model substantially outperforms frontier models (Astra, Opus, etc.) and traditional machine learning models on a tiny fraction of the compute. Already, providers are using their models to improve preventative care, pharmaceutical companies to find expanded uses for existing drugs.
Chenyan and team are obviously brilliant. They’ve led pretraining at trillion parameter scale, moved research into production systems that touched billions of people, and shipped products that improved the lives of millions of patients. Beyond their technical brilliance, I was struck most by how determined and truth-seeking the team is. When we first met Chenyan, I remarked that they had earned the trust of their early partners by underpromising and overdelivering. Chenyan corrected me — the team had correctly promised, and correctly delivered.
So I take Xlue’s promise to save millions of lives pretty seriously.
Today, Xlue is live.View quoted post on X
Xlue is building a foundation model for human health—to understand our health, predict how it evolves, and simulate how treatments can change its course.
We aim to help physicians and scientists explore outcomes before they act, from predicting disease risk to simulating clinical trials and identifying new indications for existing medicines.
Our goal is to make more of healthcare and medicine computable, turning computing power into better medicines, better care, and longer, healthier lives.
In our launch post xlue.com/news/from-medi…, we explain:
→ What Xlue does
→ What makes our approach different
→ Where we see it going
We’re very grateful to work with the team at @conviction: @pranavreddy, @mvernal, and @saranormous.
Thank you to everyone who helped us get here. This is just the start.
#HealthcareAI #HealthcareInnovation #HumanHealthModel